Dotsenko Kamila
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Dotsenko Kamila has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
- Andrey V. Zolotarev
Samara State Medical University
2 shared publications - Ionov Artem
Samara National Research University
2 shared publications - Natalya Yurievna Ilyasova
Image Processing Systems Institute, NRC “Kurchatov Institute”, Samara, Russia
2 shared publications - Nikita Demin
Samara National Research University
2 shared publications - E. Yu. Zubkova
Eroshevsky Samara Regional Clinical Ophthalmological Hospital
1 shared publication - E.V. Balandina
Eroshevsky Samara Regional Clinical Ophthalmological Hospital
1 shared publication
Latest Publications
- 1 October 2026
- Published by Springer Nature
- p. 471-480
Automatic System to Determine Indications for 2RT Treatment
- 1 October 2026
- Published by Springer Nature
- p. 471-480
Automatic System to Determine Indications for 2RT Treatment
- 8 September 2025
- Published by Media Sphere Publishing Group in Russian Annals of Ophthalmology
- Vol. 141 (4) , 60-65
Nanosecond retinal laser therapy: three years of practical experience
Objective. This study evaluated the outcomes of a 36-month follow-up after treatment with the ELLEX 2RT nanosecond laser. Material and methods. The study included 72 patients divided into two groups. Group 1 received 2RT nanosecond laser therapy, while group 2 did not undergo laser treatment. Patients with early and intermediate stages of age-related macular degeneration (AMD) were enrolled. The exclusion criteria from the study were the presence of reticular pseudodrusen, drusenoid detachment (avascular pigment epithelial detachment) measuring >1000 μm, and areas of retinal pigment epithelium (RPE) atrophy detected by optical coherence tomography (OCT). Results. After treatment, visual acuity in group 1 did not change and remained stable at 0.99, while in group 2 there was a decrease in mean uncorrected visual acuity (UCVA) from 0.98 to 0.86. In addition, OCT findings in group 1 showed no progression in 96% (41 eyes) of cases. At the same time, in 2% (1 eye) of cases, there was a significant positive trend in relation to retinal anatomy according to OCT, and in 2% (1 eye) of cases, despite some negative dynamics in retinal anatomy, there was no decrease in vision. In contrast, the disease progressed to the wet form in 19% of group 2 patients after 36 months of follow-up. According to microperimetry, retinal sensitivity in the macular area and in 2RT foci in group 1 was stable or slightly improved. There was a trend toward improved fixation on microperimetry. Conclusion. Results of the study show that after 2RT therapy the condition of the retina can stabilize or even improve, supporting the broader use of retinal laser stimulation using a nanosecond laser in patients with early forms of AMD to prevent the progression of the disease and its transition to the wet form.
- 8 September 2025
- Published by Media Sphere Publishing Group in Russian Annals of Ophthalmology
- Vol. 141 (4) , 60-65
Nanosecond retinal laser therapy: three years of practical experience
Objective. This study evaluated the outcomes of a 36-month follow-up after treatment with the ELLEX 2RT nanosecond laser. Material and methods. The study included 72 patients divided into two groups. Group 1 received 2RT nanosecond laser therapy, while group 2 did not undergo laser treatment. Patients with early and intermediate stages of age-related macular degeneration (AMD) were enrolled. The exclusion criteria from the study were the presence of reticular pseudodrusen, drusenoid detachment (avascular pigment epithelial detachment) measuring >1000 μm, and areas of retinal pigment epithelium (RPE) atrophy detected by optical coherence tomography (OCT). Results. After treatment, visual acuity in group 1 did not change and remained stable at 0.99, while in group 2 there was a decrease in mean uncorrected visual acuity (UCVA) from 0.98 to 0.86. In addition, OCT findings in group 1 showed no progression in 96% (41 eyes) of cases. At the same time, in 2% (1 eye) of cases, there was a significant positive trend in relation to retinal anatomy according to OCT, and in 2% (1 eye) of cases, despite some negative dynamics in retinal anatomy, there was no decrease in vision. In contrast, the disease progressed to the wet form in 19% of group 2 patients after 36 months of follow-up. According to microperimetry, retinal sensitivity in the macular area and in 2RT foci in group 1 was stable or slightly improved. There was a trend toward improved fixation on microperimetry. Conclusion. Results of the study show that after 2RT therapy the condition of the retina can stabilize or even improve, supporting the broader use of retinal laser stimulation using a nanosecond laser in patients with early forms of AMD to prevent the progression of the disease and its transition to the wet form.